USA – Leading food and agribusiness company Cargill has signed a binding agreement to acquire Diamond V, a provider of natural immune support products and technologies that improve animal health, animal performance and food safety.
According to Cargill, the acquisition will accelerate the company’s push to meet consumers demand for more wholesome food production to growing consumer preferences for natural and wholesome food production, building on the company’s growing animal nutrition business around the World.
“This acquisition strengthens Cargill’s and Diamond V’s shared vision to be a leader in creating new solutions for evolving consumer preferences for sustainable and wholesome food production,” said David MacLennan, Cargill’s chairman and chief executive officer.
“Our combined businesses will accelerate growth, build industry-leading capabilities and natural solutions for animal health and food safety, and help fulfill Cargill’s purpose to nourish the world in a safe, responsible and sustainable way.”
Based in Iowa, USA, Diamond V develops research-proven immune support technologies that work naturally with the biology of the animal to strengthen the immune system and promote a healthy digestive system to enhance animal health, animal performance, and food safety.
Cargill will acquire all of Diamond V’s business, including the human health business, Embria Health Sciences, and its branded products.
The company plans to use the Diamond V brand platform to make future investments in natural solutions for safer animal food production, where Cargill continues to place emphasis having invested recently in a similar company, Delacon.
The recent investment in Delacon, a leader in natural, plant-based phytogenic additives, will give Cargill the opportunity to participation in the US$20 billion global animal feed additives market, says Cargill.
The Delacon acquisition also came with key technical, regulatory and R&D capabilities and market presence in about 70 countries worldwide.
“This investment will enable Cargill’s animal nutrition business to better serve customers who are increasingly turning to unique natural technologies to unlock the potential in feed to promote healthier animals, improve performance and to help them produce safer more wholesome food,” said Cargill in a statement.
“Natural immune support products in animal feed – like natural health supplements for people — are increasingly being used to improve immunity and digestive health,” it added.
The transaction is expected to close in January 2018 after regulatory clearances. Terms of the deal were not disclosed.
